Aurora Algae Inc.

Vero Beach, FL, United States

Aurora Algae Inc.

Vero Beach, FL, United States
SEARCH FILTERS
Time filter
Source Type

Patent
Aurora Algae Inc. | Date: 2013-09-12

Provided herein are exemplary compositions, products, and capsules utilizing POA, EPA, blends of POA and EPA, total algal oil compositions, and/or whole biomass compositions in methods of inhibiting inflammation including in cardiovascular disease, diabetes, obesity, stroke, metabolic syndromes, dementia, Alzheimers disease, and/or cancer. The exemplary compositions, products, and capsules may be orally, topically, intravenously, and/or subcutaneously administered. The exemplary compositions herein may be used as feed, food, food supplements, beverages, beverage supplements, nutritional products, products for athletic performance, pharmaceutical products, and/or medical products for mammalian use, including humans.


Patent
Aurora Algae Inc. | Date: 2014-03-18

Chlorophyll deficient algal strains, methods of making chlorophyll deficient algal strains, and methods of their use are provided.


Patent
Aurora Algae Inc. | Date: 2014-03-18

The present invention provides compositions for a crude algal oil and methods of making thereof. The compositions can be used to produce a highly pure omega-3 eicosapentaenoic acid (EPA) formulation.


Patent
Aurora Algae Inc. | Date: 2014-05-13

Exemplary methods include a method for transforming an algal cell by preparing a transformation construct, preparing a particle for bombarding the algal cell, adhering the transformation construct to the particle, bombarding the algal cell with the particle, and growing the algal cell into a colony. The transformation construct is replicated within a nuclear genome of the algal cell and the growing of the algal cell is in a nutrient medium. Another exemplary method may include a method for genetically modifying an algal cell, by adding nucleic acid to the algal cell while the algal cell is suspended in a solution of low conductivity, introducing the nucleic acid into the algal cell by application of an electrical pulse resulting in a transformed algal cell, and selecting a colony that includes the transformed algal cell.


Patent
Aurora Algae Inc. | Date: 2015-10-12

Provided herein are exemplary isolated nucleotide sequences encoding polypeptides having elongase activity, which utilize fatty acids as substrates.


Patent
Aurora Algae Inc. | Date: 2013-09-12

Provided herein are exemplary total algal oil compositions comprising by total weight between approximately 0% and 99% EPA, and one or more of the following: between approximately 0% and 99% POA, less than approximately 20% saturated fats (including 0% saturated fats or substantially saturated fat free), between approximately 0% and 99% ARA, and/or between approximately 0% and 99% DHA. According to further exemplary total algal oil compositions, the saturated fats may comprise PA. Also provided herein are exemplary total algal oil compositions comprising by total weight at least 20% EPA and one or more of the following: at least 17% POA, approximately 0% to 20% saturated fats, less than approximately 10% ARA, and/or substantially no DHA. Additional exemplary total algal oil compositions may comprise by total weight at least approximately 30% EPA and one or more of the following: at least approximately 27% POA, approximately 0% to 20% saturated fats, less than approximately 10% ARA, and/or substantially no DHA.


Patent
Aurora Algae Inc. | Date: 2013-09-12

Provided herein are exemplary algal fatty acid compositions comprising by dry weight approximately 0.5% to approximately 99% C20:5 n3 Eicosapentaenoic acid (EPA) and approximately 0.5% to approximately 99% C16:1 n7 palmitoleic acid (POA). Further exemplary algal fatty acid compositions may comprise (in addition to the above) one or more of the following by dry weight: between approximately 0% and 99% arachidonic acid; between approximately 0% and 99% docosahexaenoic acid; and/or less than approximately 10% saturated fatty acids (including 0% saturated fatty acids or substantially saturated fatty acid free). Further exemplary saturated fatty acyl moiety-rich algal compositions may be in a form of an ethyl ester (EE), a mono, di- or triacylglycerol (MAG, DAG, TAG), a phospholipid (PL), a galactolipid (GL), free fatty Acid (FFA), or a sulfoquinovosyl diacylglycerol (SQDG).


Patent
Aurora Algae Inc. | Date: 2013-09-12

Provided herein are exemplary algal omega 7 compositions, including algal fatty acid compositions comprising by dry weight from about approximately 0.5% to about approximately 99% C16:1 n7 palmitoleic acid (POA). Such algal compositions may also include (either individually or any combination of) by dry weight: from about approximately 0% to about approximately 20% saturated fatty acids; from about approximately 0% to about approximately 99% arachidonic acid; from about approximately 0% to about 99% docosahexaenoic acid; and/or from about approximately 0% to about approximately 99% eicosapentaenoic acid. Further exemplary algal fatty acid compositions may include by dry weight about approximately 90% POA, less than about approximately 20% saturated fatty acids, less than about approximately 10% ARA, substantially no DHA, and less than about approximately 10% EPA.


Patent
Aurora Algae Inc. | Date: 2015-06-11

The present invention provides compositions of a modified algal cell and methods of making thereof. In particular, the modified cell has suppressed expression or activity of endogenous beta glucan synthase 1 (BGS1) and increased lipid synthesis when grown under nutrient deficient conditions.


Patent
Aurora Algae Inc. | Date: 2014-07-10

Provided herein are exemplary isolated nucleotide sequences encoding polypeptides having elongase activity, which utilize fatty acids as substrates.

Loading Aurora Algae Inc. collaborators
Loading Aurora Algae Inc. collaborators